Sunscreens, skin photobiology, and skin cancer: The need for UVA protection and evaluation of efficacy

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 1, 2000, Pages 71-78

  Gasparro, Francis P ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Critical wavelength; Long wave index; Sun protection factor; Sunburn protection factor; Ultraviolet radiation

Indexed keywords

DNA; PROTEIN P53; SUNSCREEN;

CANCER RISK; DNA DAMAGE; DRUG EFFICACY; DRUG FORMULATION; ELASTOSIS; ERYTHEMA; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; NOMENCLATURE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION PROTECTION; REVIEW; SKIN CANCER; SKIN CELL; SKIN PIGMENTATION; ULTRAVIOLET A RADIATION;

EID: 0034125398     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s171     Document Type: Review

References (111)

1. Often in this context the word "prevent" is used. Strictly speaking "prevent" means "to stop from happening." In this review, this definition will be adhered to if there are data to support the use of prevent. If the effects are reduced or minimized, these terms will be used.
2. Rcelandts R. Shedding light on sunscreens. Clin Exp Dermatol 23:147-157 (1998).
3. Roy CR, Gies HP, Lugg DJ, Tooomey S, Tomlinson DW. The measurement of solar ultraviolet radiation. Mutat Res 422:7-14 (1998).
4. Tyrrell RM. Ultraviolet radiation and free radical damage to skin. Biochem Soc Symp 61:47-53 (1995)
5. There are differences in these definitions in the United States and Europe. In the United States it is common to define UVA as 320-400 nm, whereas in Europe, the UVA range is defined as 315-400 nm. In this paper we will adhere to the former.
6. Beukers R, Berends W. Isolation and identification of the irradiation product of thymine. Biochem Biophys Acta 41:550-551 (1960).
7. Setlow RB, Carrier WL. The identification of ultraviolet induced thymine dimers in DNA by absorbante measurements. Photochem Photobiol 2:49-51 (1963).
8. Sutherland BM, Harber LC, Kochevar IE. Pyrimidine dimer formation and repair in human skin. Cancer Res 40:3181-3185 (1980).
9. Young AR, Chadwick CA Harrison GL, Nikaido O, Ramsden J Potten CS. The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophere for erythema. J Invest Dermatol 111:982-988 (1998).
10. Coblentz WW, Stair R, Hogue JM. The spectral erythemic reaction of the human skin to ultra-violet radiation. Proc Natl Acad Sci USA 17:401-405 (1931). Erythema and sunburn are not the same thing Erythema is a perceptible reddening of the skin. Severe erythema caused by an exposure to multiple MEDs results in a sunburn. In the latter case the skin undergoes a series of distinct biochemical physiologic changes.
11. Kocheva IE. Basic principles in photomedicine and photochemistry. In Clinical Photomedicine (Lim HW, Soter NA, eds). New Yark:Marcel Dekker, 1993;1-18.
12. Morliere P, Moysan A, Tirache I. Action spectrum tor UV-induced lipid peroxidation in cultured human skin fibroblasts. Free Radic Biol Med 19:365-371 (1995). The wavelength dependence for lipid damage in cultured human skin fibroblasts shows that the effectiveness of UVB compared to that of UVA is 10-100 times greater. This is one or two orders of magnitude lower than the effectiveness for the relative effects of UVB and UVA at inducing DNA damage.
13. Tyrrell RM, Pidoux M. Action spectra for human skin cells: estimates of the relative cytotoxicity of the middle ultraviolet, near ultraviolet, and violet regions of sunlight on epidermal keratinocytes. Cancer Res 47:1825-1829 (1987)
14. LeVee GJ, Sayre RM, Marolowe E. Sunscreen protection effectiveness can vary with the different simulated solar ultraviolet spectra. J Soc Cosmet Chem 31:173-177 (1980).
15. Learn DB, Beard J, Moloney SJ. The ultraviolet C energy emitted from FS lamps contributes significantly to the induction of human erythema and murine ear edema. Photodermatol Photoimmunol Photomed 9:147-153 (1993).
16. Yarosh DB, Kibitel J, Ullrich SE, Kim TH, Ananthaswamy HN, Krien P, Fourtanier A, Kripke ML. Direct comparison of DNA damage, isomerization of urocan c acid and edema in the mouse produced by three commonly used artificial UV light sources. Photochem Photobiol 69:571-574 (1999).
17. de Gruijl FR. Health effects from solar UV radiation Radial Protect Dosim 72:177-196 (1997).
18. Diffey BL. Ultraviolet radiation and human health. Clin Dermatol 16:83-89 (1998).
19. de Gruijl FR, Forbes PD. UV-induced skin cancer in a hairless mouse model. Bioessays 17:651-660 (1995).
20. Urbach F. Ultraviolet radiation and skin cancer of humans. U Photochem Photobiol B: Biology 40:3-7 (1997).
21. Ley RD. Ultraviolet radiation A-induced precursors of cutaneous melanoma in Monodelphis domestica. Cancer Res 57:3682-3684 (1997)
22. The lack of BCC and MM in animal models may reflect a fault in the experimental design. Most of these studies have been conducted using primarily UVB sources. This is an historic idiosyncrasy because for many years it was assumed that the highly energetic UVB photons were the sole culprits for human skin malignancies. More recent studies have implicated the longer portion of the solar spectrum, however, few studies have included these wavelengths in their attempts to induce BCC and MM.
23. Atillasoy ES, Seykora JT, Soballe PW, Elenitsas R, Nesbit M, Elder DE, Montone KT, Sauter E, Herlyn M. UVB induces atypical melanocytic lesions and melanoma in human skin Am J Pathol 152:1179-1186 (1998)
24. This study has been cited often since its publication as evedence that UVB is a cause of melanoma in humans!
25. Mintz B, Silvers WK Transgenic mouse model of malignant skin melanoma Proc Natl Acad Sci USA 90:8817-8821 (1993).
26. Kelsall SR, Mirtz B. Metastatic cutaneous melanoma promoted by ultraviolet radiation in mice with transgene-initiated low melanoma susceptibility. Cancer Res 58:4061-4065 (1998).
27. Carter El, Tigelaar RT, Longley BJ. Transgenic mice expressing stem cell factor in basal keratinocytes develop postinflammatory hyperpigmentation to irritant and allergic contactants [Abstract]. J Invest Dermatol 112:539 (1999).
28. Themen JP, Rouabhia M, Drobetsky EA, Drouin R. The multilayered organization of engineered human skin does not influence the formation of sunlight-induced cyclobutane pyrimidine dimers in cellular DNA Cancer Res 59:285-289 (1999).
29. de Gruijl FR, van der Leun JC. Estimate of wavelength dependency of ultraviolet carcinogenesis in humans and its relevance to the risk assessment of stratospheric ozone depletion. Health Phys 67:319-325 (1994).
30. This model illustrates the power of acton spectra studies and their application to human skin photobiology. However, to put this in perspective, it is important to note that SCC are the least common skin malignancies in humans.
31. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 329:1147-1151 (1993).
32. There are two common examples: UVB phototherapy for psoriasis and UVA tanning salons
33. Chung JH, Youn JI. Effect of ultraviolet A on IL-1 production by ultraviolet B in cultured human keratinocytes. J Dermatol Sci 9:87-93 (1995).
34. Routaboul C, Marguery MC, Gangue J, Bazex J. Influence of UVA pre-exposure on UVB-induced erythema. A Chromometric study Photodermatol Photoimmunol Photomed 15:52-58 (1999).
35. Kallias N, Malallah YH, Al-Ajmi H, Baqer A, Johnson BE, Gonzales S. Erythema and melanogenesis action spectra in heavily pigmented individuals as compared to fair-skinned Caucasians. Photodermatol Photoimmunol Photomed 12:183-138 (1995).
36. Routaboul C, Denis A, Vinche A. Immediate pigment darkening: description, kinetic and biological function. Eur J Dermatol 9:95-99 (1999).
37. Sterenborg HJ, van der Leun JC. Change in epidermal transmission due to UV-induced hyperplasia in hairless mice: a first approximation of the action spectrum. Photodermatology 5:71-82 (1988)
38. Kaidbey KH, Agin PP, Sayre RM, Kligman AM. Photoprotection by melanin - 3 comparison of black and Caucasian skin. J Am Acad Dermatol 1:249-260 (1979).
39. Holly EA, Aston DA, Cress RD, Ann DK, Kristiansen JJ. Cutaneous melanoma in women. I: Exposure to sunlight ability to tan, and other risk factors related to ultraviolet radiation. Am J Epidemiol 141:923-933 (1995).
40. Lock-Andersen J, Drzewiecki KT, Wu f HC. Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutanecus malignant melanoma A Danish case-control study. Acta Derm Venereol 79:74-80 (1999).
41. D'Errico M Calcagnile A, Iavarone I, Sera F, Baliva G, Chinni LM, Corona R, Pasquini P, Dogliotti E. Factors that influence the DNA repair capacity of normal and skin cancer-affected individuals. Cancer Epidemiol Biomarkers Prev 8:553-559 (1999).
42. Kaidbey KH, Kligman AM. Cumulative effects from repeated exposures to ultraviolet radiation J Invest Dermatol 76:352-355 (1981).
43. The Year Book on Dermatology and Dermatologic Surgery (Thiers BH, ed) New York:Mosby-Year Book, 1998;23
44. Woollons A, Kipp C, Young AR, Petit-Frere C, Arlett CF, Green MH, Clingen PH. The 0 8% ultraviolet B content of an ultraviolet A sunlamp induces 75% of cyclobutare pyrimidine dimers in human keratmocytes in vitro Br J Dermatol 140:1023-1030 (1999).
45. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ. Sunlight and sunburn in human skin cancer. 53, apoptosis, and tumor promotion. J Invest Dermatol (Symposium Proceedings) 1:136-142 (1996).
46. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241-250 (1987).
47. DiGiovanna JJ. Posttransplantation skin cancer: scope of the problem, management, and role for systemic retinoid chemo-prevention. Transplant Proc 30:2771-2775 (1998).
48. Bouwes Bavinck JN, Robertson I, Wainwright RW, Green A. Excessive numbers of skin cancers and pre-malignant skin lesions in an Australian heart transplant recipient, Br Heart J 74:468-470 (1995).
49. McGregor JM, Berkhout RJ, Rozycka M, ter Schegget J, Bouwes Bavinck JN, Brooks L, Crook T. p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status, Oncogene 15:1737-1740 (1997).
50. Daniels F, van der Leun JC, Johnson BE. Sunburn Sci Am July:16-21 (1968).
51. Pontén F, Berne B, Ren Z-P, Nister M, Pontén J. Ultraviolet light induces expression of p53 and p21 in human skin: effect of sunscreen and constitutive p21 expression in skin appendages. J Invest Dermatol 105:402-406 (1995).
52. Ananthaswamy HN, Loughlm SM, Cox P, Evans RL, Ullrich SE, Kripke ML. Sunlight and skin cancer inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens Nature Med 3:510-514 (1997).
53. Ananthaswamy HN, Ullrich SE, Mascotto RE, Fourtanier A, Loughlin SM, Khaskina P, Bucana CD, Kripke ML. Inhibition of solar simulator-induced p53 mutations and protection against skin cancer development in mice by sunscreens. J Invest Dermatol 112:763-768 (1999).
54. Strickland FM, Kripke ML. Immune response associated with nonmelanoma skin cancer. Clin Plast Surg 24:637-647 (1997).
55. Wolf P, Kripke ML, Immune aspects of sunscreens In: Sunscreen Photobiology. Ch 7 (Gasparro FP, ed). Verlag and Landes Biosciences, 1997.
56. Davenport V, Morris JF, Chu AC. Immunologic protection afforded by sunscreens in vitro. J Invest Dermatol 108:859-63 (1997).
57. Gasparro FP. Photobiology 101. J Invest Dermatol 110:183 (1998).
58. Hallicay GM, Bestak R, Yuen KS, Cavanagh LL, Barnetson RS. LIVA-induced immunosuppression. Mutat Res 422:139-45 (1998).
59. Halliday GM, Ho KK, Barnetson RS. Regulation of the skin immune system by retinoids during carcinogenesis. J Invest Dermatol 99:83S-86S (1992).
60. Colombo MP, Maccalli C, Mattel S, Melani S, fladrizzani M, Parmiani G. Local cytokme availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res 52:4853-4857 (1992).
61. Wagner SN, Schultewolter T, Wagner C, Eriedigkeit L, Becker JC, Kwasnicka HM, Goos M. Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regression. Lab Invest 76:541-550 (1998).
62. Wolf P, Donawho CK, Kripke ML. Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice. J Natl Cancer Inst 86:99-105 (1994).
63. Elmets CA, LeVine MJ, Bickers DR. Action spectrum studies for induction of immunologic unresponsiveness to dinitrofluorobenzene following in vivo low dose ultraviolet radiation. Photochem Photobiol 42:391-397 (1985).
64. DeFabo C, Noonan FP. Mechanism of immune suppression by ultraviolet irradiation in vivo, I: Evidence for the existence of a unique photoreceptor in and its role in photoimmunology. J Exp Med 158:84-98 (1983).
65. Kripke ML, Cox PA, Alas LG, Yarosh DB. Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci USA 89:7515-7520 (1992).
66. Kim TH, Ullrich SE, Ananthaswamy HN, Zimmerman S, Kripke ML. Suppression of delayed and contact hypersensitivity responses in mice have different UV dose responses. Photochem Photobiol 68:738-744 (1998).
67. This leads to a major quandary of the "catch-22" variety - we don't know enough to select a marker right now. and new information may prove any selection incorrect. The solution is not to rely on a biologic end point but rather to gauge the raw screening ability of any potential product.
68. Szepielowski J, Wasik F, Szepietowski T, Wlodarczyk M, Sobczak-Radwan K, Czyz W. Excess benign melanocytic naevi in renal transplant recipients. Dermatology 194:17-19 (1997).
69. Armstrong BK, Kricker A. Epidemiology of sun exposure and skin cancer. Cancer Surv 26:133-153 (1996).
70. D'Errico M, Calcagnile AS, Corona R, Fucci M, Annessi G, Baliva G, Tosti ME, Pasquini P, Dogliotti E. p53 mutations and chromosome instability in basal cell carcinomas developed at an early or late age. Cancer Res 57:747-752 (1997).
71. Zerp SF, van Elsas A, Peltenburg LT, Schrier Pl. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis. Br J Cancer 79:921-926 (1999).
72. Bhawan J, Andersen W, Lee J, Labadie R, Solares G. Photoaging versus intrinsic aging: a morphologic assessment of facial skin J Cutan Pathol 22:154-159 (1995).
73. Kligman LH, Sayre RM. An action spectrum for ultraviolet induced elastosis in hairless mice: quantification of elastosis by image analysis. Photochem Photobiol 53:237-242 (1991).
74. Sayre RM, Kligman LH. Action spectra for photoelastosis: a review of experimnetal techniques and predictions in "Biological responses to ultraviolet A radialion" (Urbach F, ed). Overland Park, Kansas:Valdenmar Publishing Co. 1992;83-90.
75. McCarthy EM, Ethridge KP, Wagner RF. Beach holiday sunburn: the sunscreen paradox and gender differences. Cutis 64:37-42 (1999).
76. Sterenborg HJ, van der Leun JC. Change in epidermal transmission due to UV-induced hyperplasia in hairless mice a first approximation of the action spectrum. Photodermatology 5:71-82 (1988).
77. An example of a scare tactic is to use the word epidemic in conjunction with skin cancer and specifically MM. It is important to put the incidence of skin cancer in perspective. Although increasing in incidence, skin cancer afflicts a small percentage of the population. As mentioned earlier, the least common forms are SCC and MM. For the most part, MM is the most serious threat to life, yet even considering this, one may question the use of the word epidemic in any context for skin cancer. Early detection has become much more common and hence these lesions are much more responsive to therapy or surgical excision.
78. Levy SB. Dihydroxyacetone-containing sunless or self-tanning lotions. J Am Acad Dermatol 27:989-993 (1992).
79. Garty M, Stull R, Kopin IJ, Goldstein DS. Skin color, aging, and plasma L-dopa levels. J Auton Nerv Syst 26:261 -263 (1989).
80. Brown DA, Ren WY, Khorlin A, Lesiak K, Conklin D, Watanabe KA, Seidman MM, George J. Aliphatic and a icyclic diols induce melanogenesis in cultured cells and guinea pig skin J Invest Dermatol 110:428-437 (1998).
81. Gilchrest BA, Park H-Y, Eller MS. Yaar M. Mechanisms of ultraviolet light-induced pigmentation. Photochem Photobiol 63:1-10 (1996).
82. Pawelek J, Platt J, Pugliese PT. and Chakraborty AK, Enzymatic and non-enzymatic synthesis of melanins. In: Melanin: Its Role in Human Photoprotection. Overland Park, KS:Valdenmar Publishing Co. 1995;109-115.
83. Moan J, Dahlback A, Setlow RB. Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation. Photochem Photobiol 70:243-247 (1999).
84. Marrot L, Belaidi J-P, Meunier J-R, Ferez P, Agappakis-Causse C. The human melanocyte as a particular target for UVA radiation and an endpoint for photoprotection assessment Photochem Photobiol 69:686-693 (1999)
85. Wood JM, Jimbow K, Boissy RE, Slommski A, Plonka PM, Slawinski J, Wortsman J, Tosk J. What's the use of generating melanin? Eur Dermatol 8:153-164 (1999).
86. These kind of studies that re-evaluate ong-standing hypotheses are essential as we attempt to unravel puzzling aspects of epidemiologic studies that appear to be in conflict.
87. 3. Science 211:590-593 (1981).
88. Ainsleigh HG. Beneficial effects of sun exposure on cancer mortality. Prev Med 22:132-140 (1993).
89. Levins PC, Carr DB, Fisher JE, Momtaz K, Parrish JA. Plasma beta-endorphin and beta-lipoprotein response to ultraviolet radiation Lancet 2(8342):166 (1983).
90. Armstrong BK, Kricker A. Epidemiology of sun exposure and skin cancer. In: Skin Cancer, Vol 26 (Leigh IM, Newton Bishop JA, Kripke ML, eds). Plainview, NY:Cold Spring Harbor Laboratory Press, 1996:133-154.
91. Koh HK. Preventive strategies and research for ultraviolet-associated cancer Environ Health Perspect 103(suppl 8):255-257 (1995).
92. It has often been claimed that sunscreen users do not spend more time in the sun (none published). Therefore, in epidemiology studies showing that an increased incidence of skin cancer correlates with sunscreen use attributing the effects to underapplying sunscreens needs to be reconsidered as a possible explanation for unexpected correlations.
93. Willis I, Cylus L. UVA erythema in skin: is it a sunburn? U Invest Dermatol 68:128-129 (1977).
94. Berg RJ, de Laat A, Roza L, van der Leun JC, de Gruiji FR. Substitution of equally carcinogenic UV-A for UV-B irradiations lowers epidermal thymine dimer levels during skin cancer induction in hairless mice. Carcinogenesis 16:2455-2459 (1995).
95. The final FDA sunscreen monograph. Fed Reg 64 (98):27666-27693
96. Sayre RM, Dowdy JC. Photostability testing of avobenzone. Cosm Toiletries 114:86-90 (1999).
97. Although some have been impatient with the lag between the FDA temporary monograph issued in 1979 and final monograph in 1999, it should be noted that much has been learned about skin photobiology in these two decades. It also appears prudent that the FDA las chosen not to rush the publication of UVA guidelines, as there is still much to be learned in this area.
98. Rosenstein BS, Weinstock MA, Habib R. Transmittance spectra and theoretical sun protection factors for a series of sunscreen-containing sun care products Photodermatol Photoimmunol Photomed 15:75-80 (1999).
99. Cole CA, Davies RE, Forbes PD, D'Aloisio LC. Comparison of action spectra for acute cutaneous responses to ultraviolet radiation: man and albino hairless mouse. Photochem Photobiol 37:623-631 (1983).
100. Kvam E, Tyrrell RM. Induction of exidative DNA base damage in human skin cells by UV and near visible radiation. Carcinogenesis 18:2379-2384 (1997).
101. Black G, Matzinger E, Gange RW. Lack of photoprotection against UVB-induced erythema by immediate pigmentation induced by 382 nm radiation. J Invest Dermatol 85:448-449 (1985).
102. Kawada A, Hiruma M, Nakada R, Kukita A. An evaluation of broad-spectrum sunscreens against topical PUVA-induced erythema. Acta Derm Venereol 69:335-337 (1989).
103. Diffey BL. Indices of protection from in vitro assay of sunscreens In: Sunscreens Development, Evaluation, and Regulatory Aspects 2nd ed (Lowe NJ, Shaath NA, Pathak MA. eds) NewYork:Marcel Dekker, 1997;589-600.
104. Diffey BL. A method for broad spectrum classification of sunscreens, Int J Cosmet Sci 16:47-52 (1994).
105. Once assigned oxymoron status, several reports have documented the existence of sunscreen photochemistry However, other than the potential impact on product efficacy (SPF), no deleterious effect in human skin has been attributed to such a phenomenon
106. Stokes R, Diffey B. How well are sunscreen users protected? Photodermatol Photoimmurol Photomed 13:186-188 (1997).
107. Bech-Thomsen N, Wulf HC. Sunbathers' application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation. Photodetmatol Photoimmunol Photomed 9:242-244 (1992-93).
108. See Table 2 for new regulations that become effective in 2001. 109. From the product label for Heliotherapy (www.caltan.com)
109. Autier P, Dore JF, Negrier S, Lienard D, Panizzon R, Lejeune FJ, Guggisberg D, Eggermont AM. Sunscreen use and duration of sun exposure: a double-blind, randomized trial. J Natl Cancer Inst 91:1304-1309 (1999).
110. Geller CA Current status of sun protection programs. Cosm Dermatol 12:43-47 (1999).
111. Kollias N, Gillies H, Anderson RR. The non-invasive determination of UVA sunscreen effectiveness in vivo. In: Biological Responses to Ultraviolet A Radiation (Urbach F. ed). Overland Park, Kansas:Valdenmar Publishing Co, 1992;371-376.